Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.

Oncology reports - 1 Jul 2008

Georgieva Milka, Krasteva Maria, Angelova Elka, Ralchev Krassimir, Dimitrov Valentin, Bozhimirov Stanislav, Georgieva Elena, Berger Martin R

Abstract excerpt

Colorectal cancer patients may succumb to their disease because of local recurrence or formation of metastasis. To develop a prognostic tool for these fatal types of progression, 23 patients with colorectal carcinoma were included in this study for the detection at the time of surgery of the incidence of K-ras, B-raf and p53 mutations, the phosphorylation status of Erk and the expression of cystatin-like...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Cystatins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Extracellular Signal-Regulated MAP Kinases

Share to Genes, p53

Share to Genes, ras

Share to MAP Kinase Signaling System

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 18575712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.PMID 18575712Read ↗

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.Semantic proximity Read ↗

Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.Semantic proximity Read ↗

Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.Semantic proximity Read ↗

ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.Semantic proximity Read ↗

APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.Semantic proximity Read ↗

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.Semantic proximity Read ↗

Clinical-pathological correlation of K-Ras mutation and ERK phosphorylation in colorectal cancer.Semantic proximity Read ↗

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.Semantic proximity Read ↗

Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.Semantic proximity Read ↗

Raf Kinase Inhibitor Protein Expression in a Survival Analysis of Colorectal Cancer PatientsSemantic proximity Read ↗

[K-ras mutational status and tumour-infiltrating lymphocytes in human colon cancer: state of the art and future perspectives].Semantic proximity Read ↗

Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.